Coloplast is currently undergoing a pivotal transition after major acquisitions and leadership changes. Find out why CLPBF ...

Coloplast A/S (ISIN DK0060448595) stock is trading close to recent highs as of August 28, 2026, with investors weighing ...

Aug 18 (Reuters) - Medical equipment maker Coloplast expects its Kerecis wound-care business to return to growth from January 2027 after changes to U.S. Medicare payments caused sales in outpatient ...

Coloplast remains a 'Buy,' trading ~20% below intrinsic value despite recent struggles and special charges. Organic growth was 6% in Q2-25/26, but reported results were impacted by a DKK 3 billion ...

The company aims to expand its position within advanced wound care by introducing a new silicone foam that will benefit both healthcare professionals and patients. "We are now introducing new ...

Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO. As the company is entering into a new strategy ...

Coloplast stock trades modestly higher around DKK460 on August 28, 2026, as a fresh analyst target lift and a valuation debate draw investor attention ahead of the company’s next annual results.

Coloplast announces changes to Executive Leadership Team. Today, Coloplast announces two changes to the company’s Executive Leadership Team (ELT). The changes strengthen the lea ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

COPENHAGEN, July 7 (Reuters) - Coloplast (COLOb.CO), opens new tab has agreed to buy Iceland-based Kerecis, a biologic wound care firm that uses fish skin to develop tissue-transplant products, for up ...

Add Yahoo as a preferred source to see more of our stories on Google. Aug 18 (Reuters) - Medical equipment maker Coloplast expects its Kerecis wound-care business to return to growth from January 2027 ...